scholarly journals Structure of HIV-1 Vpr in complex with the human nucleotide excision repair protein hHR23A

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
In-Ja L. Byeon ◽  
Guillermo Calero ◽  
Ying Wu ◽  
Chang H. Byeon ◽  
Jinwon Jung ◽  
...  

AbstractHIV-1 Vpr is a prototypic member of a large family of structurally related lentiviral virulence factors that antagonize various aspects of innate antiviral immunity. It subverts host cell DNA repair and protein degradation machineries by binding and inhibiting specific post-replication repair enzymes, linking them via the DCAF1 substrate adaptor to the Cullin 4 RING E3 ligase (CRL4DCAF1). HIV-1 Vpr also binds to the multi-domain protein hHR23A, which interacts with the nucleotide excision repair protein XPC and shuttles ubiquitinated proteins to the proteasome. Here, we report the atomic resolution structure of Vpr in complex with the C-terminal half of hHR23A, containing the XPC-binding (XPCB) and ubiquitin-associated (UBA2) domains. The XPCB and UBA2 domains bind to different sides of Vpr’s 3-helix-bundle structure, with UBA2 interacting with the α2 and α3 helices of Vpr, while the XPCB domain contacts the opposite side of Vpr’s α3 helix. The structure as well as biochemical results reveal that hHR23A and DCAF1 use overlapping binding surfaces on Vpr, even though the two proteins exhibit entirely different three-dimensional structures. Our findings show that Vpr independently targets hHR23A- and DCAF1- dependent pathways and highlight HIV-1 Vpr as a versatile module that interferes with DNA repair and protein degradation pathways.

2019 ◽  
Vol 2019 ◽  
pp. 1-8
Author(s):  
Joseph W. George ◽  
Mika Bessho ◽  
Tadayoshi Bessho

Gemcitabine (2′, 2′-difluorodeoxycytidine; dFdC) is a deoxycytidine analog and is used primarily against pancreatic cancer. The cytotoxicity of gemcitabine is due to the inhibition of DNA replication. However, a mechanism of removal of the incorporated dFdC is largely unknown. In this report, we discovered that nucleotide excision repair protein XPF-ERCC1 participates in the repair of gemcitabine-induced DNA damage and inactivation of XPF sensitizes cells to gemcitabine. Further analysis identified that XPF-ERCC1 functions together with apurinic/apyrimidinic endonuclease (APE) in the repair of gemcitabine-induced DNA damage. Our results demonstrate the importance of the evaluation of DNA repair activities in gemcitabine treatment.


2011 ◽  
Vol 18 (2) ◽  
pp. 191-197 ◽  
Author(s):  
Marcin Jaciuk ◽  
Elżbieta Nowak ◽  
Krzysztof Skowronek ◽  
Anna Tańska ◽  
Marcin Nowotny

2000 ◽  
Vol 460 (3-4) ◽  
pp. 277-300 ◽  
Author(s):  
Karsten Theis ◽  
Milan Skorvaga ◽  
Mischa Machius ◽  
Noriko Nakagawa ◽  
Bennett Van Houten ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document